{"id":"W2148764617","doi":"10.2310/6620.2009.09010a","title":"A Mechanism-Based Classification of Dermatologic Reactions to Biologic Agents Used in the Treatment of Cutaneous Disease: Part 1","year":2009,"lang":"en","type":"article","venue":"Dermatitis","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Dermatology; Efalizumab; Etanercept; Adalimumab; Infliximab; Rituximab; Atopic dermatitis; Disease; Hidradenitis suppurativa; Progressive multifocal leukoencephalopathy; Malignancy; Acne; Rheumatoid arthritis; Immunology; Pathology; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004798505,0.0001189482,0.0002560751,0.0001974415,0.00004409275,0.000005453757,0.00007792765,0.00006056247,0.00002064799],"category_scores_gemma":[0.00008893516,0.00008228562,0.0001063076,0.0003736608,0.00003251751,0.00004023908,0.000003091154,0.00005745735,0.00002716363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001514267,"about_ca_system_score_gemma":0.00008993245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006012117,"about_ca_topic_score_gemma":0.00003458132,"domain_scores_codex":[0.9990251,0.00009981562,0.0003621037,0.0001574356,0.0001893263,0.0001662138],"domain_scores_gemma":[0.9991761,0.0001293863,0.0001503806,0.0003911645,0.00005490686,0.00009806079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003848714,0.05538836,0.2015758,0.001433178,0.0009355217,0.005436819,0.02384416,0.004704517,0.3511436,0.04912245,0.01352471,0.292506],"study_design_scores_gemma":[0.001247126,0.0003830868,0.9285961,0.0001900504,0.0002015762,0.0002484259,0.0007468349,0.002090751,0.01453475,0.0007749861,0.0508431,0.0001431663],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815971,0.00004182132,0.0006004961,0.01452474,0.00009338278,0.001002209,0.0000791472,0.00005050776,0.002010616],"genre_scores_gemma":[0.9978037,0.0001065651,0.0003749896,0.001431466,0.00001885005,0.00009509915,0.0001149313,0.00000616656,0.0000482444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7270203,"threshold_uncertainty_score":0.335551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06136117568961141,"score_gpt":0.3151911916170957,"score_spread":0.2538300159274843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}